Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 17/20 | 0.58 |
| ▸ | NPY1R | P25929 | 10/20 | 0.58 |
| ▸ | NPY5R | Q15761 | 9/20 | 0.58 |
| ▸ | NPY2R | P49146 | 6/20 | 0.58 |
| ▸ | CHRND | Q07001 | 2/20 | 0.53 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.53 |
| ▸ | CHRNG | P07510 | 1/20 | 0.53 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7867793 | 1.00 | NPY4R (0.58) | NPY4RNPY1RNPY5RNPY2RCHRND | |
| SCHEMBL7866090 | 0.92 | CHRND (0.56) | CHRNDCHRNA1CHRNGCHRNB1 | |
| SCHEMBL24122752 | 0.92 | CHRND (0.56) | CHRNDCHRNA1CHRNGCHRNB1 | |
| SCHEMBL7866097 | 0.92 | CHRND (0.56) | CHRNDCHRNA1CHRNGCHRNB1 | |
| SCHEMBL30521958 | 0.91 | NPY4R (0.53) | NPY4RNPY1RNPY5RNPY2RCHRND | |
| SCHEMBL29630348 | 0.89 | QRFPR (0.53) | NPY4RNPY1RNPY5RNPY2RCHRND | |
| SCHEMBL30309259 | 0.89 | NPY4R (0.65) | NPY4RNPY1RNPY5RNPY2RCHRND | |
| SCHEMBL31232421 | 0.88 | TFPI (0.56) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL31257079 | 0.88 | NPY4R (0.64) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29735603 | 0.88 | CHRND (0.56) | CHRNDCHRNA1CHRNGCHRNB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6303116-B1 | CAPABLE OF TRANSDUCING THERAPEUTIC GENES INTO NON-DIVIDING CELLS. | THOMAS JEFFERSON UNIVERSITY | 2001-10-16 | — | — | US | disclosed |